诊断用药物剂量学的准确性:基于全器官S值计算时所纳入源组织数量的影响
本研究利用已发表的68Ga-DOTA-TATE数据集,评估在ICRP体素模体和Cristy-Eckerman(CE)程式化模体中纳入不同数量源组织对有效剂量系数e的影响。结果显示,e随纳入源组织数量变化:ICRP体素模体为14.0-23.5 μSv/MBq,CE程式化模体为12.4-27.7 μSv/MBq;纳入ICRP体素模体14个源组织中的5个(36%)或CE程式化模体12个源组织中的3个(25%)后,e与使用全部源组织相比差异小于10%。
要点
- 纳入较大组织(如肌肉和全身剩余组织)对剂量学计算很重要。
- ICRP体素模体达到e稳定需纳入5/14(36%)个源组织,CE程式化模体需纳入3/12(25%)个源组织。
- 全部源组织纳入计算时e约为将时间积分活度浓度分布合并为单一全身剩余源项时的2倍。
核心结论
- 本研究表明在剂量学计算中纳入较大组织(如肌肉和全身剩余组织)很重要。
- 基于ICRP第103号出版物组织权重因子的ICRP体素模体,其e随纳入组织的变化范围小于基于ICRP第60号出版物组织权重因子的CE程式化模体。
研究设计与样本
- 本研究使用先前发表的68Ga-DOTA-TATE数据集,比较ICRP体素模体和CE程式化模体中纳入源组织数量对有效剂量系数e的影响。
主要发现
- 根据纳入源组织数量不同,e在ICRP体素模体中为14.0-23.5 μSv/MBq,在CE程式化模体中为12.4-27.7 μSv/MBq。
- e稳定性定义为使用全部源组织与使用较少源组织所得e差异小于10%,ICRP体素模体在纳入14个源组织中的5个(36%)后达到,CE程式化模体在纳入12个源组织中的3个(25%)后达到。
- 与将时间积分活度浓度分布合并为单一全身剩余源项相比,纳入全部源组织时e增加2倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dosimetry for diagnostic agents is performed to assess the risk of radiation detriment (e.g., cancer) associated with the imaging agent and the risk is assessed by computing the effective dose coefficient, e. Stylized phantoms created by the MIRD Committee and updated by work performed by Cristy-Eckerman (CE) have been the standard in diagnostic dosimetry. Recently, the ICRP developed voxelized phantoms, which are described in ICRP Publication 110. These voxelized phantoms are more realistic and detailed in describing human anatomy compared with the CE stylized phantoms. Ideally, all tissues should be represented and their pharmacokinetics collected for an as accurate a dosimetric calculation as possible. As the number of source tissues included increases, the calculated e becomes more accurate. There is, however, a trade-off between the number of source tissues considered, and the time and effort required to measure the time-activity curve for each tissue needed for the calculations. In this study, we used a previously published 68Ga-DOTA-TATE data set to examine how the number of source tissues included for both the ICRP voxelized and CE stylized phantoms affected e. RESULTS: Depending upon the number of source tissues included e varied between 14.0-23.5 μSv/MBq for the ICRP voxelized and 12.4-27.7 μSv/MBq for the CE stylized phantoms. Furthermore, stability in e, defined as a < 10% difference between e obtained using all source tissues compared to one using fewer source tissues, was obtained after including 5 (36%) of the 14 source tissues for the ICRP voxelized, and after including 3 (25%) of the 12 source tissues for the CE stylized phantoms. In addition, a 2-fold increase in e was obtained when all source tissues where included in the calculation compared to when the TIAC distribution was lumped into a single reminder-of-body source term. CONCLUSIONS: This study shows the importance of including the larger tissues like the muscles and remainder-of-body in the dosimetric calculations. The range of e based on the included tissues were less for the ICRP voxelized phantoms using tissue weighting factors from ICRP Publication 103 compared to CE stylized phantoms using tissue weighting factors from ICRP Publication 60.
引用
- Josefsson A, Siritantikorn K, Ranka S, et al. Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations. EJNMMI Res. 2020. PMID: 32189087. doi:10.1186/s13550-020-0614-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。